Two-stage or RSABE [Regulatives / Guidelines]
Dear Dr. Gunasakaran!
Thanks for pointing that out (lines 125-127); it slipped through my attention. Apart from a potential delay – any recent experiences from our members how long the review process at the FDA takes? – I’m really fine with that.
❝ For applicants wishing to use variations of these study designs or analysis methods (e.g., a sequential design or scaled-average BE, we recommend that you submit a complete protocol for review and comment before starting the study."
Thanks for pointing that out (lines 125-127); it slipped through my attention. Apart from a potential delay – any recent experiences from our members how long the review process at the FDA takes? – I’m really fine with that.
- Sequential designs
I’m positive about the acceptance of Potvin’s Method C and its derivatives. FDA’s CDER cosponsored PQRI’s studies and FDA’s Donald Schuirmann is one of the authors; these are the variants they recommended (not Method B!). See also product-specific guidances on Loteprednol Etabonate / Tobramycin (06/2012) and Loteprednol Etabonate (04/2013).
- RSABE
Gives an opportunity to clarify whether TYPE=FA0(1)instead ofTYPE=FA0(2)might be used in evaluating the partial replicate design (due to convergence issues with the latter if unscaled ABE has to be applied) or
- a fully replicated three-period design (i.e., TRT|RTR) is an acceptable alternative.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- Draft FDA Guidance Dec 2013 pash413 2013-12-04 15:05
- First impressions Helmut 2013-12-04 16:47
- First impressions nasir 2014-02-14 06:47
- What is Bioequivalence in the US really? ElMaestro 2013-12-07 23:34
- Site of action vs. systemic circulation Helmut 2013-12-08 02:05
- Draft FDA Guidance Dec 2013 drgunasakaran1 2013-12-08 08:39
- Two-stage or RSABEHelmut 2013-12-08 13:59
- Two-stage or RSABE ElMaestro 2013-12-08 14:17
- Two-stage methods Helmut 2013-12-08 14:44
- Two-stage methods ElMaestro 2013-12-08 18:56
- Two-stage methods Helmut 2013-12-08 14:44
- RSABE Lucas 2014-03-24 17:05
- Two-stage or RSABE ElMaestro 2013-12-08 14:17
- Draft FDA Guidance Dec 2013 jag009 2013-12-09 22:31
- Draft FDA Guidance Dec 2013 kvgreddy06 2014-02-14 16:44
- Two-stage or RSABEHelmut 2013-12-08 13:59
- End of consultation approaching‼ Helmut 2014-02-26 11:32
- End of consultation approaching‼ wien-ui 2014-03-01 08:05
- End of consultation approaching‼ Helmut 2014-03-01 20:09
- End of consultation approaching‼ wien-ui 2014-03-04 10:53
- End of consultation approaching‼ Helmut 2014-03-01 20:09
- End of consultation approaching‼ wien-ui 2014-03-01 08:05
- First impressions Helmut 2013-12-04 16:47
